VYNE Therapeutics Inc. (VYNE) Gets Buy Reaffirmation on Pipeline Progress
VYNE Therapeutics Inc. (NASDAQ:VYNE) is among the fundamentally strong penny stocks to invest in. Analysts at H.C. Wainwright have reaffirmed their Buy rating on VYNE Therapeutics Inc.